Cargando…
A global analysis of the value of precision medicine in oncology – The case of non-small cell lung cancer
OBJECTIVES: Biomarker testing is indispensable for the implementation of precision medicine (PM) in oncology. The aim of this study was to assess the value of biomarker testing from a holistic perspective based on the example of advanced non-small cell lung cancer (aNSCLC). MATERIALS AND METHODS: A...
Autores principales: | Hofmarcher, Thomas, Malmberg, Chiara, Lindgren, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986274/ https://www.ncbi.nlm.nih.gov/pubmed/36891190 http://dx.doi.org/10.3389/fmed.2023.1119506 |
Ejemplares similares
-
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
por: Sundar, Raghav, et al.
Publicado: (2017) -
Precision Medicine and Global Health: The Good, the Bad, and the Ugly
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2018) -
Cardio oncology: Digital innovations, precision medicine and health equity
por: Sadler, Diego, et al.
Publicado: (2022) -
Corrigendum: Precision Medicine and Global Health: The Good, the Bad, and the Ugly
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2018) -
Editorial: Precision Medicine in Veterinary Oncology
por: Fonseca-Alves, Carlos Eduardo, et al.
Publicado: (2021)